Skip to content

Key resources

  • Bibliography
    Bibliography
  • Health promotion
    Health promotion
  • Health practice
    Health practice
  • Yarning places
    Yarning places
  • Programs
    Programs
  • Organisations
    Organisations
  • Conferences
    Conferences
  • Courses
    Courses
  • Funding
    Funding
  • Glossary
    Glossary
AOD workers' portal
 

General: National

2014

Gowing L, Ali R, Dunlop A, Farrell M, Lintzeris N (2014)

National guidelines for medication-assisted treatment of opioid dependence.

Canberra: National Drug Strategy

This document is intended to provide a broad policy context and a framework for medication-assisted treatment of opioid dependence.

It provides clinical guidelines on approaches involving the use of methadone, buprenorphine or naltrexone for the treatment of opioid dependence. It aims to provide guidance in the selection and management of patients seeking pharmacotherapies for opioid dependence, and to support the provision to patients of accurate information about methadone, buprenorphine and naltrexone.

Information includes:

  • treatment planning
  • detoxification
  • substitution treatment
  • relapse prevention: naltrexone maintenance treatment
  • good clinical practice.

This document updates and replaces four previously separate documents:

  • National pharmacotherapy policy for people dependent on opioids
  • Clinical guidelines and procedures for the use of methadone in the maintenance treatment of opioid dependence
  • National clinical guidelines and procedures for the use of buprenorphine in the maintenance treatment of opioid dependence
  • Clinical guidelines and procedures for the use of naltrexone in the management of opioid dependence.

Abstract adapted from National Drug Strategy

2013

National Pharmaceutical Drug Misuse Framework for Action Project Team (2013)

National pharmaceutical drug misuse framework for action (2012-2015).

Canberra: Australian National Council on Drugs

2011

Ministerial Council on Drug Strategy (2011)

National drug strategy 2010-2015.

Canberra: Australian Government

The National drug strategy 2010-2015 is a framework for action on alcohol, tobacco and other drugs.

The aim of the National drug strategy 2010-2015 is to build safe and healthy communities by minimising alcohol, tobacco and other drug-related health, social and economic harms among individuals, families and communities.

The National drug strategy 2010-2015 is divided into three parts:

  • Part 1 provides background and explains the conceptual framework of the strategy
  • Part 2 details specific objectives and suggested actions under each pillar
  • Part 3 discusses the supporting approaches of workforce, evidence, performance monitoring and governance.

Abstract adapted from the National drug strategy

2007

Intergovernmental Committee on Drugs (2007)

National pharmacotherapy policy: for people dependent on opioids.

Canberra: Australian Government Department of Health and Ageing for National Drug Strategy

2001

Ali R, Biggs L, Dorlego B, Gill T, Larkins K, Moyle K, Murray T, Perrin J, Quiqley A, Rysavy P, Sunjic S, Wilson C, Richards I (2001)

National buprenorphine policy.

Canberra: Department of Health and Ageing

 
Last updated: 15 July 2014
 
Return to top
spacing
general box

Contribute

Share your information » Give us feedback »
spacing
 
spacing
 


Australia's National Research Centre on AOD Workforce Development National Drug and Alcohol Research Centre National Drug Research Institute